2114 studies found for:    PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Show Display Options
Rank Status Study
1 Recruiting Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Chronic Obstructive Lung Disease;   Chronic Obstructive Airway Disease;   Chronic Bronchitis;   Emphysema
Interventions: Behavioral: Mindfulness-based cognitive therapy;   Behavioral: Pulmonary rehabilitation
2 Completed Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions
Conditions: Chronic Obstructive Pulmonary Disease;   Exacerbation of Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: Bundle tool
3 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Osteopenia
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
4 Recruiting Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Conditions: COPD;   COPD Exacerbation;   Lung Diseases;   Respiratory Disorders;   Pulmonary Disease;   Chronic Obstructive Lung Diseases;   Chronic Obstructive Airway Disease
Interventions: Drug: Roflumilast;   Drug: Placebo
5 Completed Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Prednisolone
6 Completed Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: SB681323
7 Completed A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Respiratory Tract Diseases;   Chronic Obstructive Airway Disease;   COPD
Interventions: Drug: placebo;   Drug: active comparator;   Drug: PF-03635659
8 Recruiting Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease
Conditions: Moderate Chronic Obstructive Pulmonary Disease;   Severe Chronic Obstructive Pulmonary Disease;   Dyspnea
Intervention: Drug: Combination ipratropium/salbutamol or placebo (nebulization)
9 Completed Advair® DISKUS® (Fluticasone Propionate/Salmeterol) Versus Serevent® DISKUS® (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Salmeterol;   Drug: Fluticasone Propionate/Salmeterol Combination Product
10 Completed A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Airway Disease
Interventions: Drug: GW856553;   Drug: Placebo;   Drug: Seretide
11 Recruiting Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Conditions: Lung Diseases, Obstructive;   Pulmonary Disease, Chronic Obstructive;   Bronchitis, Chronic
Intervention: Device: Yamax Digi-Walker CW-700
12 Completed Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Airflow Obstruction, Chronic;   Chronic Obstructive Airway Disease;   Chronic Obstructive Lung Disease
Intervention: Device: Breathe Technologies Noninvasive Open Ventilation (NIOV™) System
13 Completed Chronic Obstructive Pulmonary Disease Endpoints Study
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Fluticasone Propionate/Salmeterol 500/50mcg combination;   Drug: Fluticasone Propionate 500mcg;   Drug: Salmeterol 50mcg
14 Completed A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: GW856553
15 Completed Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: salmeterol;   Drug: tiotropium;   Drug: GSK233705
16 Recruiting Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive;   Pulmonary Emphysema;   Bronchitis, Chronic;   Lung Diseases;   Disease Progression
Intervention:
17 Completed A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Lung Diseases, Obstructive
Interventions: Drug: PF-00610355;   Drug: PF - 00610355;   Drug: PF- 00610355;   Drug: Placebo;   Drug: Salmeterol
18 Recruiting A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: CNTO 6785;   Drug: Placebo
19 Completed Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Formoterol Fumarate
20 Completed
Has Results
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol 300 μg;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years